Approvals/TGA/TRAJENTAMET 2.5 mg/850 mg linagliptin 2.5 mg / metformin hydrochloride 850 mg film-coated tablet blister pack

Approved

STANDARD

TRAJENTAMET 2.5 mg/850 mg linagliptin 2.5 mg / metformin hydrochloride 850 mg film-coated tablet blister pack

Boehringer Ingelheim Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: e668de2bf9b49657
Product Name: TRAJENTAMET 2.5 mg/850 mg linagliptin 2.5 mg / metformin hydrochloride 850 mg film-coated tablet blister pack
Artg Id: 195101
Artg Name: TRAJENTAMET 2.5 mg/850 mg linagliptin 2.5 mg / metformin hydrochloride 850 mg film-coated tablet blister pack
Sponsor: Boehringer Ingelheim Pty Ltd
Company Detail Path: /organization/boehringer-ingelheim-pty-ltd
Artg Date: 2013-05-21
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/eb9b72eb3c522d1ff140393480eb8878.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/123a9c1865d09029815a4e7431b6386b.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

e668de2bf9b49657

Type

Standard